Not Yet RecruitingNCT07681869
Effects of Nimodipine on Alcohol Drinking
Medication studyAges 21–50United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 21 years to 50 years.
- Listed locations
- New HavenSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: September 1, 2026
- Recruitment status
- Not Yet Recruiting
- Enrollment listed in the registry
- 40
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 21 Years to 50 Years
- Official registry ID
- NCT07681869
- Official title
Show the full official title
A Randomized Controlled Study on the Effects of Nimodipine on Alcohol Drinking Among Adults Who Are Heavy Alcohol Drinkers
Recruitment & locations
Not yet recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New Haven
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Does this study involve medication?
Yes. The study involves medication, including Nimodipine and Placebo.
Who can participate?
Listed age limits: 21 years to 50 years.
Is this study still recruiting?
The registry lists this study as not yet recruiting.
